Inhibiting the E3 ubiquitin ligase activity of BIRC3 can increase tumor cell sensitivity to radiotherapy and chemotherapy, and developing BIRC3 inhibitors may offer a promising approach for treating glioblastoma. The gene discussed is BIRC3; the disease is neoplasm.